Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I, Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Patients With Solid Tumors, including Pancreatic Cancer, or Lymphoma

Summary

The purpose of this phase I study is to evaluate the safety of orally administered VMD-928 in adult patients with advanced solid tumors, including pancreatic cancer, or lymphoma that have progressed or are non responsive to available therapies and for which no standard or available curative therapy exists.

General Information

NCT#: NCT03556228
Study ID: VMO-01C
Trial Phase: Phase I

Trial Sponsor: VM Oncology, LLC
Therapies Used in This Trial: VMD-928

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search